Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul Senior who wrote (47243)	6/30/2012 11:10:32 AM
From: E_K_S	Read Replies (2) of 78741

Way to stay w/ holding some of your AMLN shares. I sold my shares over two years ago. I was not patient enough to wait for their value proposition to develop. Their offer is up to $31.00/share from their earlier offer of $21.00/share in February. Bristol-Myers To Buy Diabetes Maker Amylin For $5.3 Billion goo.gl --------------------------------------------------------------- I have cut back on my pharma holdings in recent years but still own shares in BMY, PFE, MRK, ABT, NSRGY (This one has a drug spin w/ their baby formula). Now that Obama health care passed, it might be time to build up positions in this sector as value candidate present themselves. I maintain a 16 stock Drug/Pharma watch list that I monitor and BAYRY is one I like a lot. I missed the recent drop below $60.00 (6/5/2012) and now the stock has gaped up to $71.50/share. LLY, MDT, COV, BDX & GSK all sell at reasonable PE's but none for me at this time are screaming value buys. EKS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next